Correlation Between Viridian Therapeutics and Dice Molecules
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Dice Molecules at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Dice Molecules into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Dice Molecules Holdings, you can compare the effects of market volatilities on Viridian Therapeutics and Dice Molecules and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Dice Molecules. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Dice Molecules.
Diversification Opportunities for Viridian Therapeutics and Dice Molecules
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Viridian and Dice is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Dice Molecules Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dice Molecules Holdings and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Dice Molecules. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dice Molecules Holdings has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Dice Molecules go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Dice Molecules
If you would invest 4,697 in Dice Molecules Holdings on November 4, 2024 and sell it today you would earn a total of 0.00 from holding Dice Molecules Holdings or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 5.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. Dice Molecules Holdings
Performance |
| Timeline |
| Viridian Therapeutics |
| Dice Molecules Holdings |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Viridian Therapeutics and Dice Molecules Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and Dice Molecules
The main advantage of trading using opposite Viridian Therapeutics and Dice Molecules positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Dice Molecules can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dice Molecules will offset losses from the drop in Dice Molecules' long position.| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
| Dice Molecules vs. Nuvalent | Dice Molecules vs. Arcellx | Dice Molecules vs. Vaxcyte | Dice Molecules vs. Viridian Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |